Phadia develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.
January 26, 2010
Phadia Brings the First and Only Point of Care In Vitro Specific IgE Allergy Test Into the Physician’s Office with Final FDA Clearance of the ImmunoCAP® Rapid System
Read more »